Notably, these results could be recapitulated by adding recombinant human plexin B2 (rhPlexin B2) on patient-derived CRC organoids (PDOs) with or without immortalized human hepatocytes (PTA-5565) (Fig. 1k and Extended Data Fig. 3i,j). This evidence concerns the gene PLXNB2 and colorectal carcinoma.